USPTO serial 79455124
EMD HEALTHCARE
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOHNSON, BRITTANY S
- Law office
- TMO LAW OFFICE 126
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with EMD HEALTHCARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations; sanitary preparations for medical purposes; dietary food and substances adapted for medical use; pharmaceutical preparations for the treatment of diseases and disorders in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases; pharmaceutical preparations for the treatment of tumors, neurofibromatosis, multiple myeloma; prefilled syringes containing choriogonadotropin alfa; prefilled syringes containing follitropin alfa; prefilled syringes containing lutropin alfa; prefilled syringes containing interferon beta-1 a; prefilled syringes containing cetrorelix; small molecule therapeutic preparations for the treatment of tumors, cancer, rare diseases, neurofibromatosis, multiple myelom, and diseases in the oncological and neuro-oncological fields. | ACTIVE | — |
| 009 | Downloadable software applications for mobile devices in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma; downloadable software applications for mobile applications that enable users to access medical and pharmaceutical information in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma | ACTIVE | — |
| 010 | Medical apparatus, instruments and equipment; medical apparatus, instruments and equipment, namely, injection devices for pharmaceuticals; syringes for medical purposes; hypodermic syringes; needles for injections | ACTIVE | — |
| 035 | Business management and consultation services in the medical and pharmaceutical field; conducting business conferences in the medical and pharmaceutical field | ACTIVE | — |
| 041 | Educational services; providing of training; educational services, namely, conducting training, conferences and workshops in the medical and pharmaceutical fields; providing training about the administration of drugs; conducting educational conferences and workshops in the medical and pharmaceutical fields; providing educational information in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma | ACTIVE | — |
| 042 | Scientific and technological services; scientific and technological services, namely research and development in the medical and pharmaceutical field; providing online non-downloadable software for medical and pharmaceutical applications in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma | ACTIVE | — |
| 044 | Providing medical information, consultancy and advisory services; providing medical and pharmaceutical patient support services in the nature of disease management information, treatment options, and medical advice in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma; providing pharmaceutical information about drug treatments and therapeutic properties | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Merck KGaA
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EMD HEALTHCARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |